Physicians Financial Services Inc. Sells 1,398 Shares of The Procter & Gamble Company (NYSE:PG)

Physicians Financial Services Inc. cut its position in The Procter & Gamble Company (NYSE:PG) by 5.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,795 shares of the company’s stock after selling 1,398 shares during the quarter. Procter & Gamble makes up about 1.4% of Physicians Financial Services Inc.’s holdings, making the stock its 18th biggest position. Physicians Financial Services Inc.’s holdings in Procter & Gamble were worth $4,468,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Itau Unibanco Holding S.A. bought a new position in shares of Procter & Gamble during the 2nd quarter worth about $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble during the second quarter valued at about $29,000. Ruedi Wealth Management Inc. raised its holdings in Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $34,000. Finally, Quest Partners LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $36,000. 65.77% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 313,597 shares of company stock valued at $53,268,499 over the last 90 days. 0.18% of the stock is owned by corporate insiders.

Procter & Gamble Stock Performance

Shares of NYSE:PG traded up $2.05 on Friday, hitting $165.46. The company had a trading volume of 1,034,089 shares, compared to its average volume of 6,635,311. The stock has a 50 day moving average price of $171.29 and a 200 day moving average price of $168.13. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a market cap of $389.66 billion, a price-to-earnings ratio of 28.17, a P/E/G ratio of 3.57 and a beta of 0.42. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter last year, the company earned $1.83 earnings per share. Analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. Procter & Gamble’s payout ratio is 69.48%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. increased their target price on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. TD Cowen started coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target on the stock. Evercore ISI lifted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Finally, Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.